| 
 21 CFR Part 820.250 
AIHA-LAP Policies 2018 2A.7.7.1.3 
ASTM E1578-18 E-10-2 
EPA 815-R-05-004 Chap. IV, Sec. 7.2.8 
EPA 815-R-05-004 Chap. VI, Sec. 7.8 
E.U. Commission Reg. No. 2073/2005 Article 9 
FDA Hazard Analysis Critical Control Point Principle 4
 
 | 
18.2 The system should allow authorized users to choose specific sample types, tests, and parameters associated with the statistical trending and control charts that can be generated.
 |